COVID-19 Impact on Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: CD2D398BA6AFEN
QYResearch

Abstracts

This report focuses on the global Peyronie’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peyronie’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Endo International
• Asahi Kasei
• BioSpecifics Technologies
• ...

Market segment by Type, the product can be split into

• Drugs
• Surgery

Market segment by Application, split into

• Hospital
• Drugs Store

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Peyronie’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Peyronie’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Peyronie’s Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peyronie’s Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Peyronie’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drugs
  1.4.3 Surgery
1.5 Market by Application
  1.5.1 Global Peyronie’s Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Store
1.6 Coronavirus Disease 2019 (Covid-19): Peyronie’s Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Peyronie’s Disease Treatment Industry
    1.6.1.1 Peyronie’s Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Peyronie’s Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Peyronie’s Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Peyronie’s Disease Treatment Market Perspective (2015-2026)
2.2 Peyronie’s Disease Treatment Growth Trends by Regions
  2.2.1 Peyronie’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Peyronie’s Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Peyronie’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Peyronie’s Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Peyronie’s Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Peyronie’s Disease Treatment Players by Market Size
  3.1.1 Global Top Peyronie’s Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Peyronie’s Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Peyronie’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peyronie’s Disease Treatment Market Concentration Ratio
  3.2.1 Global Peyronie’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Peyronie’s Disease Treatment Revenue in 2019
3.3 Peyronie’s Disease Treatment Key Players Head office and Area Served
3.4 Key Players Peyronie’s Disease Treatment Product Solution and Service
3.5 Date of Enter into Peyronie’s Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Peyronie’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Type (2021-2026)

5 PEYRONIE’S DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Peyronie’s Disease Treatment Market Size by Application (2015-2020)
5.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Peyronie’s Disease Treatment Market Size (2015-2020)
6.2 Peyronie’s Disease Treatment Key Players in North America (2019-2020)
6.3 North America Peyronie’s Disease Treatment Market Size by Type (2015-2020)
6.4 North America Peyronie’s Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Peyronie’s Disease Treatment Market Size (2015-2020)
7.2 Peyronie’s Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Peyronie’s Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Peyronie’s Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Peyronie’s Disease Treatment Market Size (2015-2020)
8.2 Peyronie’s Disease Treatment Key Players in China (2019-2020)
8.3 China Peyronie’s Disease Treatment Market Size by Type (2015-2020)
8.4 China Peyronie’s Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Peyronie’s Disease Treatment Market Size (2015-2020)
9.2 Peyronie’s Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Peyronie’s Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Peyronie’s Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Peyronie’s Disease Treatment Market Size (2015-2020)
10.2 Peyronie’s Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peyronie’s Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Peyronie’s Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Peyronie’s Disease Treatment Market Size (2015-2020)
11.2 Peyronie’s Disease Treatment Key Players in India (2019-2020)
11.3 India Peyronie’s Disease Treatment Market Size by Type (2015-2020)
11.4 India Peyronie’s Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Peyronie’s Disease Treatment Market Size (2015-2020)
12.2 Peyronie’s Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Peyronie’s Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Peyronie’s Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Endo International
  13.1.1 Endo International Company Details
  13.1.2 Endo International Business Overview and Its Total Revenue
  13.1.3 Endo International Peyronie’s Disease Treatment Introduction
  13.1.4 Endo International Revenue in Peyronie’s Disease Treatment Business (2015-2020))
  13.1.5 Endo International Recent Development
13.2 Asahi Kasei
  13.2.1 Asahi Kasei Company Details
  13.2.2 Asahi Kasei Business Overview and Its Total Revenue
  13.2.3 Asahi Kasei Peyronie’s Disease Treatment Introduction
  13.2.4 Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2015-2020)
  13.2.5 Asahi Kasei Recent Development
13.3 BioSpecifics Technologies
  13.3.1 BioSpecifics Technologies Company Details
  13.3.2 BioSpecifics Technologies Business Overview and Its Total Revenue
  13.3.3 BioSpecifics Technologies Peyronie’s Disease Treatment Introduction
  13.3.4 BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2015-2020)
  13.3.5 BioSpecifics Technologies Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Peyronie’s Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Peyronie’s Disease Treatment Revenue
Table 3. Ranking of Global Top Peyronie’s Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peyronie’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Surgery
Table 7. COVID-19 Impact Global Market: (Four Peyronie’s Disease Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Peyronie’s Disease Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Peyronie’s Disease Treatment Players to Combat Covid-19 Impact
Table 12. Global Peyronie’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Peyronie’s Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Peyronie’s Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Peyronie’s Disease Treatment Market Share by Regions (2015-2020)
Table 16. Global Peyronie’s Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Peyronie’s Disease Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Peyronie’s Disease Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Peyronie’s Disease Treatment Players
Table 23. Global Peyronie’s Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Peyronie’s Disease Treatment Market Share by Players (2015-2020)
Table 25. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peyronie’s Disease Treatment as of 2019)
Table 26. Global Peyronie’s Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Peyronie’s Disease Treatment Product Solution and Service
Table 29. Date of Enter into Peyronie’s Disease Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Peyronie’s Disease Treatment Market Size Share by Type (2015-2020)
Table 33. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Peyronie’s Disease Treatment Market Size Share by Application (2015-2020)
Table 35. Global Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Peyronie’s Disease Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 39. North America Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 41. North America Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 45. Europe Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 47. Europe Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 51. China Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 53. China Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 57. Japan Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 59. Japan Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 63. Southeast Asia Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 69. India Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 71. India Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Peyronie’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Peyronie’s Disease Treatment Market Share (2019-2020)
Table 75. Central & South America Peyronie’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Peyronie’s Disease Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Peyronie’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Peyronie’s Disease Treatment Market Share by Application (2015-2020)
Table 79. Endo International Company Details
Table 80. Endo International Business Overview
Table 81. Endo International Product
Table 82. Endo International Revenue in Peyronie’s Disease Treatment Business (2015-2020) (Million US$)
Table 83. Endo International Recent Development
Table 84. Asahi Kasei Company Details
Table 85. Asahi Kasei Business Overview
Table 86. Asahi Kasei Product
Table 87. Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2015-2020) (Million US$)
Table 88. Asahi Kasei Recent Development
Table 89. BioSpecifics Technologies Company Details
Table 90. BioSpecifics Technologies Business Overview
Table 91. BioSpecifics Technologies Product
Table 92. BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2015-2020) (Million US$)
Table 93. BioSpecifics Technologies Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Peyronie’s Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Surgery Features
Figure 4. Global Peyronie’s Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Peyronie’s Disease Treatment Report Years Considered
Figure 8. Global Peyronie’s Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Peyronie’s Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Peyronie’s Disease Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Peyronie’s Disease Treatment Market Share by Players in 2019
Figure 13. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peyronie’s Disease Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Peyronie’s Disease Treatment Revenue in 2019
Figure 15. North America Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Peyronie’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Endo International Revenue Growth Rate in Peyronie’s Disease Treatment Business (2015-2020)
Figure 24. Asahi Kasei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Asahi Kasei Revenue Growth Rate in Peyronie’s Disease Treatment Business (2015-2020)
Figure 26. BioSpecifics Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. BioSpecifics Technologies Revenue Growth Rate in Peyronie’s Disease Treatment Business (2015-2020)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed